Ozempic shows slightly stronger post-meal glucose reduction, which contributes to its overall superior A1C lowering ability
1 Anti-Obesity Medications: Injectable GLP-1 RAs for Weight Reduction Glucagon-like peptide 1 receptor agonists (GLP-1 RAs), initially designed for treating type 2 diabetes, have emerged as not only effective in regulating blood sugar levels but also in fostering weight loss
Structurally similar to fructose, allulose provides approximately 0.4 kilocalories per gramabout 10% of the energy content of regular sugarand is minimally metabolised by the human body
Rodents have higher metabolic rates relative to body mass, different adipose tissue distribution, and a brown fat compartment that is more metabolically active
Animal research has also described accelerated repair of tendon, ligament, muscle, bone and gut tissue , alongside cytoprotective and anti-inflammatory activity particularly protection of the gastrointestinal lining [2] [4]
Wei and colleagues (Wei et al., 2022) recently discovered that GLP-1 receptor activation inhibits this signaling pathway by modulating ROCK activity, leading to a reduction in the phosphorylation of MLC, which stabilizes the endothelial cell cytoskeleton and tight junctions by upregulating the expression of tight junction proteins such as Occludin and ZO-1